Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Submitted by
admin
on August 9, 2013 - 10:00am
Source:
Fierce Biotech
News Tags:
Ariad Pharmaceuticals
FDA
non-small cell lung cancer
AP26113
Headline:
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Do Not Allow Advertisers to Use My Personal information
